Q3 2013 Holdings
Filed 2013-11-14 | 127 holdings | $514.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec Inc(BIIB) | COM | 09062X103 | $247.1M | 1,026,400 | 48.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $114.2M | 1,581,700 | 22.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $77.9M | 1,742,000 | 15.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $36.8M | 766,000 | 7.2% |
| Cerus Corp(CERS) | COM | 157085101 | $17.2M | 2,557,900 | 3.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $8.6M | 312,000 | 1.7% |
| Catalyst Pharm Partners Inc(CPRX) | COM | 14888U101 | $5.8M | 1,895,000 | 1.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $2.0M | 170,000 | 0.4% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $300.4K | 4,777,800 | 0.1% |
| Amgen Inc(AMGN) | COM | 031162100 | $294.3K | 2,629,600 | 0.1% |
| Merck & Co Inc New(MRK) | COM | 58933Y105 | $289.3K | 6,076,000 | 0.1% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $240.8K | 5,204,000 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $201.5K | 1,307,000 | 0.0% |
| Mylan Inc | COM | 628530107 | $192.7K | 5,049,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $170.6K | 4,473,000 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $160.5K | 513,100 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $148.5K | 2,151,607 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $142.5K | 1,546,000 | 0.0% |
| Medivation Inc | COM | 58501N101 | $136.9K | 2,284,500 | 0.0% |
| HCA Holdings Inc(HCA) | COM | 40412C101 | $130.5K | 3,053,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $128.8K | 1,593,800 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $115.2K | 4,010,400 | 0.0% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $115.1K | 2,246,000 | 0.0% |
| Express Scripts Hldg Co | COM | 30219G108 | $110.2K | 1,783,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $103.4K | 2,852,500 | 0.0% |
| Wellpoint Inc | COM | 94973V107 | $100.8K | 1,206,000 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $99.4K | 1,553,000 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $95.2K | 1,329,000 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $82.8K | 690,900 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $80.0K | 4,592,600 | 0.0% |
| Actavis Inc | COM | 00507K103 | $68.4K | 475,100 | 0.0% |
| Impax Laboratories Inc | COM | 45256B101 | $67.3K | 3,285,700 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $65.3K | 1,834,000 | 0.0% |
| Cubist Pharmaceuticals Inc | COM | 229678107 | $57.5K | 904,200 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $56.6K | 653,000 | 0.0% |
| Warner Chilcott PLC Ireland | SHS A | G94368100 | $56.2K | 2,449,100 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $55.2K | 4,680,300 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $50.9K | 8,744,000 | 0.0% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $50.4K | 300,000 | 0.0% |
| Intermune Inc | COM | 45884X103 | $44.4K | 2,887,600 | 0.0% |
| Carefusion Corp | COM | 14170T101 | $44.4K | 1,203,300 | 0.0% |
| Affymetrix Inc | COM | 00826T108 | $41.2K | 6,648,000 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $41.0K | 3,114,500 | 0.0% |
| Health NET Inc | COM | 42222G108 | $40.2K | 1,269,600 | 0.0% |
| Cigna Corporation | COM | 125509109 | $33.7K | 438,000 | 0.0% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $33.6K | 200,000 | 0.0% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $31.1K | 1,416,608 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $30.1K | 4,831,600 | 0.0% |
| Orasure Technologies Inc(OSUR) | COM | 68554V108 | $29.2K | 4,860,100 | 0.0% |
| Allergan Inc | COM | 018490102 | $26.9K | 297,000 | 0.0% |